Radiopharmaceuticals Procurement for Naval Medical Centers by Defense Health Agency
⚠ Important Legal Notice
This is a Request for Information (RFI) to identify potential sources possessing the capabilities described herein and ascertain whether the required supplies are commercial in nature. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offer will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.
Executive Summary
The Defense Health Agency is seeking sources for the procurement of radiopharmaceuticals for multiple Naval Medical Centers. This contract will be an Indefinite Delivery, Indefinite Quantity (IDIQ) type.
⚠ Important Notice Details
Submission Requirements:
- Responses to the RFI shall adhere to the following formatting and outline instructions:
- All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.
- Cover Page (1 page)
- – Title
- – Organization
- – Responder’s technical and administrative points of contact (names, addresses, phone numbers and email addresses).
- – CAGE Code
- Capabilities statement SHALL address the following:
- – Contractor’s clear understanding and ability to perform the scope of this requirement as detailed in the DRAFT SOW.
- – Contractor’s experience performing the same or similar work as detailed in the DRAFT SOW.
- – Existing contract vehicles (e.g., GSA schedule) under which the responder currently offers these services, if any.
- – Whether the responder provides the required services to the general public under terms and conditions similar to those offered to the Federal Government.
- RESPONSES DUE: Sunday, April 26, 2026 by 5 pm EST
- SUBMISSION TO: Ms. Carol Uebelacker, [email protected]
Response Deadline: April 26, 2026 9:00 PM
Need help writing a winning proposal?
Our partner network includes certified proposal writers with proven win rates across DLA, Army, Navy, and civilian agencies.
Scope & Requirements
This is a Request for Information (RFI) to identify potential sources possessing the capabilities described herein and ascertain whether the required supplies are commercial in nature. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offer will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.
NOTE: Currently no solicitation exists. Therefore, please do not request a copy of the solicitation. NO PHONE CALLS WILL BE ACCEPTED. It is the responsibility of any potential Offeror to monitor this site for the release of any solicitation.
- RFI Title: Radiopharmaceuticals for the Defense Health Agency (DHA) Multiple Medical Treatment Facilities (MTF).
- LOCATIONS: Naval Medical Center Portsmouth, Portsmouth, VA 23708, Naval Medical Center Camp Lejeune, Jacksonville, NC and Naval Health Clinic Jacksonville, FL.
- BACKGROUND: Three (3) Medical Treatment Facility (MTF) Radiology Departments require one new Indefinite Delivery, Indefinite Quantity contract for the delivery of radiopharmaceuticals, as current contracts expire on September 30, 2026. The radiopharmaceuticals need to be delivered on an as needed basis to each requiring Radiology Department.
- DESCRIPTION: NAICS 325412 Pharmaceutical Preparation Manufacturing, PSC 6505 Drugs and Biologicals. See DRAFT Statement of Work (SOW).
Compliance & Qualifications
- Standard FAR clauses apply.
How to Prepare Your Bid
- Ensure your capabilities statement clearly demonstrates your understanding of the requirements outlined in the DRAFT Statement of Work.
- Highlight any previous experience with similar contracts to establish credibility.
- Include information on existing contract vehicles that may facilitate your ability to provide these services.
Stop losing contracts because of avoidable mistakes.
This checklist covers the 12 critical steps government evaluators look for — and most small businesses miss.
Why Small Businesses Should Consider This
This contract presents a significant opportunity for small businesses, particularly those in the pharmaceutical manufacturing sector, as it falls under NAICS code 325412. The Indefinite Delivery, Indefinite Quantity (IDIQ) contract structure allows for flexibility and the potential for multiple task orders, which can be advantageous for small firms looking to establish long-term relationships with federal agencies.
Additionally, the focus on radiopharmaceuticals highlights a niche market that may not be as competitive, allowing small businesses with the right capabilities to stand out and secure contracts.